Analysis of cellular function of DYRK family protein kinases
Analysis of cellular function of DYRK family protein kinases
批准号:
17570110
负责人:
MIYATA Yoshihiko
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
Dyrk(双特异性酪氨酸磷酸化调节蛋白激酶)家族由DYRK1A、DYRK1B、DYRK2、DYRK3和DYRK4几个相关蛋白激酶组成。DYRKs与果蝇小脑有显著的同源性,人类21号染色体上的DYRK1a被证明与人类唐氏综合症有关。在这里,我们报告了与DYRKs特定成员相关的细胞蛋白的鉴定。分子量为90、70和50 kDa的细胞蛋白,与DYRK1B和DYRK4特异结合,但不与其他DYRKs结合。这些蛋白分别被鉴定为分子伴侣Hsp90、Hsp70和CDC37。GFP-DYRKs的显微分析表明,DYRK1A和DYRK1B为细胞核,而DYRK2、DYRK3和DYRK4主要为细胞质。用特定的Hsp90抑制剂格尔达那霉素处理细胞,可以消除Hsp90和CDC37与DYRK1B和DYRK4的关联,但不能消除Hsp70的关联。抑制Hsp90分子伴侣活性影响DYRK1B和DYRK4的细胞内动力学,但不影响其他DYRKs。DYRK1B和DYRK4在用格尔达霉素处理细胞后迅速形成胞质斑点,提示Hsp90的伴侣功能是阻止靶蛋白的蛋白聚集所必需的。长时间抑制Hsp90会降低DYRK1B和DYRK4的细胞水平,但不会降低其他DYRKs的水平。最后,DYRK1B和DYRK4在细胞中被特异性泛素化,而泛素化的DYRK1B和DYRK4被蛋白酶体抑制进一步增加。综上所述,这些结果表明,Hsp90和CDC37区分Dyrk激酶家族的特定成员,并且是这些客户激酶在细胞中的溶解性和稳定性所必需的。
英文摘要
The DYRK (Dual-specificity tYrosine-phosphorylation Regulated protein Kinase) family consists of several related protein kinases, DYRK1A, DYRK1B, DYRK2, DYRK3, and DYRK4. DYRKs show significant homology to Drosophila Minibrain, and DYRK1A in human chromosome 21 has been shown to be responsible for the human Down's syndrome. Here we report identification of cellular proteins that associate with specific members of DYRKs. Cellular proteins with molecular masses of 90, 70, and 50-kDa associated specifically with DYRK1B and DYRK4, but not with other DYRKs. These proteins were identified as molecular chaperones Hsp90, Hsp70, and Cdc37, respectively. Microscopic analysis of GFP-DYRKs showed that DYRK1A and DYRK1B were nuclear, while DYRK2, DYRK3, and DYRK4 were mostly cytoplasmic. Treatment of cells with the specific Hsp90 inhibitor, geldanamycin, abolished the association of Hsp90 and Cdc37 with DYRK1B and DYRK4, but not of Hsp70. Inhibition of Hsp90 molecular chaperone activity affected the intracellular dynamics of DYRK1B and DYRK4, but not other DYRKs. DYRK1B and DYRK4 underwent rapid formation of cytoplasmic punctate dots after treatment of cells with geldanamycin, suggesting that the chaperone function of Hsp90 is required for the prevention of protein aggregation of target kinases. Prolonged inhibition of Hsp90 decreased the cellular levels of DYRK1B and DYRK4, but not other DYRKs. Finally, DYRK1B and DYRK4 were specifically ubiquitinated in cells, and the ubiquitinated DYRK1B and DYRK4 further increased by proteasome inhibition. Take together, these results indicate that Hsp90 and Cdc37 discriminate specific members of the DYRK kinase family and are required for the solubility and stability of these client kinases in cells.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
分子シャペロンHsp90阻害薬(ゲルダナマイシン)
分子伴侣 Hsp90 抑制剂(格尔德霉素)
DOI:
--
发表时间:
2005
期刊:
癌治療と宿主 17
影响因子:
--
作者:
[Miyata, Y., Nishida, E., 宮田 愛彦]
通讯作者:
宮田 愛彦
An inhibitor of the molecular chaperone Hsp90 (geldanamycin) (in Japanese)
分子伴侣 Hsp90(格尔德霉素)的抑制剂(日语)
DOI:
--
发表时间:
2005
期刊:
Frontiers in Cancer Treatment 17
影响因子:
--
作者:
[Miyata, Y.]
通讯作者:
Y.
DOI:
10.1007/s11010-005-2949-8
发表时间:
2005-06-01
期刊:
MOLECULAR AND CELLULAR BIOCHEMISTRY
影响因子:
4.3
作者:
[Miyata, Y, Nishida, E]
通讯作者:
Nishida, E
Identification and functional analyses of cellular proteins that specifically interact with DYRK family protein kinases
-
批准号:20570129
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:MIYATA Yoshihiko
-
依托单位:
Analysis of physiological role of protein kinase MOK, a novel member of MAP kinase superfamily
-
批准号:13680781
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:MIYATA Yoshihiko
-
依托单位:
Identification and functional analysis of a novel type of MAP kinase superfamily.
-
批准号:11680696
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:MIYATA Yoshihiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
EB病毒类朊蛋白EBNA1通过分子伴侣HSP90调控相分离促进鼻咽癌恶性进展的机制研究
-
批准号:2026JJ60271
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张宵月
-
依托单位:
富血小板血浆外泌体通过靶向雪旺细胞sFRP1-巨噬细胞HSP90轴减轻神经病理性疼痛的机制研究
-
批准号:2026JJ81668
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:左玲玲
-
依托单位:
分子伴侣Hsp90/FKBP51复合物通过稳定PPARγ减轻糖尿病心缺血再灌注损伤的机制研究
-
批准号:JCZRYB202500986
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
西花蓟马热休克蛋白Hsp90与番茄斑萎病毒NSs蛋白互作调控介体传毒机制研究
-
批准号:2025JJ60138
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈建斌
-
依托单位:
载HSP90抑制剂的工程化细胞外囊泡激活STING信号通路逆转KRAS/STK11共突变肺腺癌抗PD-(L)1治疗原发耐药的研究
-
批准号:82503714
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:李锋
-
依托单位:
HSP90介导的新型GPX4降解剂的设计、合成及铁死亡响应的抗肿瘤耐药研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:董金云
-
依托单位:
转录相关蛋白Tap1介导热休克蛋白Hsp90乙酰化在白念珠菌致病性中的作用机制研究
-
批准号:QN25H110013
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王琦琦
-
依托单位:
马尔尼菲篮状菌细胞外囊泡携载Hsp90通
过TLR4/NF-κB/NLRP3途径介导巨噬细胞
焦亡导致播散感染的机制并作为诊断标
志物的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:胡秀梅
-
依托单位:
激光热疗经肿瘤细胞分泌富含HSP90的外泌体激活NLRP3介导巨噬细胞M1极化的机制研究
-
批准号:2025JJ70425
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:龙珊
-
依托单位:
响应性纳米材料靶向抑制Hsp90的内耳保护效应及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:贾高干
-
依托单位: